Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Key Movement
    • Stryker names...

    Stryker names Meenakshi Nevatia as New MD for India

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-10-09T10:00:18+05:30  |  Updated On 9 Oct 2018 10:00 AM IST
    Stryker names Meenakshi Nevatia as New MD for  India
    Prior to joining Stryker, Nevatia had a 15-year stint with Novartis. In her last assignment as the country president and pharma division head for Novartis in Thailand, she led a strong business performance.

    New Delhi: Michigan-based Fortune 500 medical technology firm Stryker has announced a new head of Indian operations as part of its plan to tap the highly lucrative market, especially after the recent launch of Ayushman Bharat.


    As Stryker's new managing director for India, Meenakshi Nevatia will be responsible for building business strategy and setting up the organisation for a long-term, sustainable growth in the Indian market, a media release said.


    Additionally, one of Nevatia's priorities will be to cultivate a strong commitment to Stryker's mission and values in India, it said.


    Prior to joining Stryker, Nevatia had a 15-year stint with Novartis. In her last assignment as the country president and pharma division head for Novartis in Thailand, she led a strong business performance. She has also served in various leadership positions at Novartis across Spain, Portugal, the UK and Switzerland


    "Customers and patients are at the heart of everything we do, and I look forward to bringing together our team to do more to improve lives in India," Nevatia said.


    "I also look forward to creating an environment where our people, one of our core values, can continue to thrive and grow," she added in a statement.


    Nevatia has a Master of Business Administration in Strategy and Finance from the Indian Institute of Management, Ahmedabad, and a Bachelor of Science in Economics and Mathematics from the Presidency College, Kolkata.

    Ayushman BharatFortune 500 medical technologyIIM ahmedabadIndian Institute of ManagementMeenakshi NevatiaNovartisStryker
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok